12 OKT 2021

Public cash offer by Advent and GIC of SOBI

TIN Fonder has assessed the public cash offer for Swedish Orphan Biovitrum AB. In the assessment of the offer, we have also incorporated an opinion of valuation from external valuation providers and expert networks. Our conclusion is that the current cash offer does not fully reflect the mid-term improved outlook for the ongoing business and long-term growth prospects of the Company.


Risk information
Historical returns are no guarantee of future returns. The money invested in the fund can both increase and decrease in value and it is not certain that an investor will get back all the invested capital. Please read Fact Sheets (PRIIP) and prospectuses available on our website or contact a distributor.
Edit cookie settings